Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Regeneron Pharmaceuticals Inc (REGN), iShares Russell 2000 Index (ETF) (IWM), Brightcove Inc (BCOV): Some Trendy Stocks On Wednesday

Editor’s note: Related tickers: Regeneron Pharmaceuticals Inc (NASDAQ:REGN), iShares Russell 2000 Index (ETF) (NYSEARCA:IWM), Brightcove Inc (NASDAQ:BCOV), Allergan, Inc. (NYSE:AGN), Smith & Wesson Holding Corporation (NASDAQ:SWHC)

A good way to follow stocks is by tracking the most trended stocks on the website. Among these stocks we can mention: Regeneron Pharmaceuticals Inc (NASDAQ:REGN), iShares Russell 2000 Index (ETF) (NYSEARCA:IWM), Brightcove Inc (NASDAQ:BCOV), Allergan, Inc. (NYSE:AGN), Smith & Wesson Holding Corporation (NASDAQ:SWHC).

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is trading 13.64% higher at $244.49. According to a proxy filing with the Securities and Exchange Commission, Leonard S. Schleifer, president and CEO of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) earned about $30 million in 2012, which is almost three times more than a year before. At the same time, the Chief Scientific Officer and president, George D. Yancopoulos received even more, about $81.5 million, which, compared to 2011 earnings of $10 million, represents an increase by about 8 times. “Our common stock was the top performing NASDAQ stock for a company with a market capitalization greater than $5 billion over the past one- and three-year periods, and the top performing stock among our Peer Group over the past one-, three- and five-year periods,” Regeneron Pharmaceuticals Inc (NASDAQ:REGN) also said in the filing.

The ETF iShares Russell 2000 Index (ETF) (NYSEARCA:IWM) has also made the list. Currently iShares Russell 2000 Index (ETF) (NYSEARCA:IWM) is trading 2.15% lower at $92.11. According to Reuters, iShares Russell 2000 Index (ETF) (NYSEARCA:IWM) looks for investment results that usually agree to the price and yield of the Russell 2000 Index, which comprises about 8% of the market capitalization of all publicly traded U.S. equity securities.

Brightcove Inc (NASDAQ:BCOV) jumped by 27.91% to $7.70 amid positive financial results. Total revenue of Brightcove Inc (NASDAQ:BCOV) in the first quarter of 2013 totalled $24.7 million, which represents a 24% increased compared to the previous year. Brightcove Inc (NASDAQ:BCOV) also posted a $16.3 million gross profit in the first quarter of 2013, against $13.6 million a year ago, the company said in a statement. It added that Brightcove Inc (NASDAQ:BCOV) expects revenue between $25.7 million and $26.2 million for the second quarter of 2013, while for the whole 2013, it estimates revenue to amount to $104 million to $106 million.

Allergan, Inc. (NYSE:AGN) is the next on our list showing a 12.51% decline to $99.15. According to a statement issued today, Allergan, Inc. (NYSE:AGN) posted $0.89 diluted EPS, compared to $0.74 a year ago. The sales of the company increased by an annual 8.4% to $1.4 billion. At the same time, Allergan, Inc. (NYSE:AGN) expects sales between $5.98 billion and $6.20 billion over the whole 2013, while for the second quarter the sales are estimated at between $1.5 billion and $1.58 billion. The statement added that Allergan, Inc. (NYSE:AGN)’s Board of Directors announced a first quarter dividend amounting to $0.05 per share.

Smith & Wesson Holding Corporation (NASDAQ:SWHC) declined by 2.37% to $8.57. According to our database, 25 hedge funds held Smith & Wesson Holding Corporation (NASDAQ:SWHC) in their equity portfolio.

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!